“…Different simple HPLC-UV procedures based on direct HPLC injection after sample deproteinization or even without sample pretreatment have been reported for the individual determination of LTG [10][11][12][13], MHD [14] and FBM [15,16] in human plasma. Shortcomings of these methods for TDM in patients with epilepsy include the need for dual-wavelength monitoring [10] or a gradient elution [15] to eliminate interferences, low analyte extraction efficiency [14], inadequate limit of quantitation (LOQ) [11], inappropriate choice of the internal standard [16] and short guard column [14] or column life [12]. Only one recently published method allows for the simultaneous determination of LTG and MHD [17], but it requires laborious and expensive sample pre-treatment.…”